Articles
Permission marketing and pharma: how to get it right

Permission marketing and pharma: how to get it right

Invasive, one-way marketing messages are increasingly ineffective, but if customers feel they are respected, they are more open to receiving – and ultimately acting on – messages that are tailo

Articles
Cancer-cells-16-9

Is the Cancer Drugs Fund beyond fixing?

Barbara McLaughlan discusses England's Cancer Drugs Fund (CDF) and suggests ways of securing a new, sustainable assessment and funding model for cancer medicines.

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

R&D